Panel discussion

An IEP catalogs all existing and planned evidence, and seeks to identify unmet evidence requirements, dependencies, and common themes across different categories of evidence. Join our panel-discussion with biotech and IQVIA expert-panelists to learn more about IEP and why you should integrate it into your clinical development early on to draw more value from your data. IEP also supports with maximizing the value of your asset and optimizing access to patients.

Our panel draws from the broad experience of leveraging an IEP in biotech’s, we will include early stage biotech start up founders, a biotech CEO with a first product launch, an ISPOR board member discussing the recommendations for evidence gathering and IEPs as well as IQVIA experts that can give examples of how IEPs are leveraged across the industry.